Creative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsThe advent of Chimeric Antigen Receptor T-cell (CAR-T) therapies has revolutionized the field of oncology, providing new avenues for treating various forms of cancer. Our 20 years of experience in the biotechnology sector have equipped us with the expertise and technological capabilities to support the entire lifecycle of CAR-T products, from early development to commercialization.
EXPLORE MORETo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsGet a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORE
Tumor-infiltrating lymphocyte (TIL) therapy has emerged as a promising immunotherapy approach, specifically for melanoma and other cancers. The process begins with isolating lymphocytes from the patient's tumor, followed by their expansion in vitro. These expanded TILs are then reintroduced into the patient, aiming to target and eliminate cancer cells. Functional assays play an important role in the development and optimization of TIL therapeutics. At Creative Biolabs, we offer comprehensive services designed to maximize the therapeutic potential of TILs through precise expansion and functional testing. Our functional assay services include a variety of assays designed to evaluate the cytotoxicity and cytokine release capabilities of expanded TILs, ensuring their therapeutic potential.
Expanded TIL Cytotoxicity Assay
Our cytotoxicity assays are designed to measure the ability of expanded TILs to effectively kill cancer cells. This assay provides direct evidence of the cytotoxic potential of TILs, ensuring they retain their anti-tumor activity post-expansion.
Expanded TIL Cytokine Release Assay
Our cytokine release assays are meticulously designed to quantify the release of key cytokines, such as IFN-gamma, TNF-alpha, and IL-2, which are indicative of TIL activation and functionality.
By leveraging cutting-edge technologies and methodologies, Creative Biolabs is committed to enhancing the therapeutic potential of TIL therapy. Our functional assays help determine the ability of TILs to recognize and destroy cancer cells, and their capacity to produce critical cytokines — factors that are vital for anti-tumor responses. We have a team of experienced scientists to deliver precise, reliable, and reproducible results. We partner with our clients, offering tailored solutions and expert guidance throughout the testing process, ensuring that each therapeutic development journey is supported by the highest standards of scientific rigor. We promise precision, reliability, and a commitment to helping our partners achieve groundbreaking advances in cancer immunotherapy.
At Creative Biolabs, we are dedicated to supporting every stage of the TIL development process. From the initial isolation of TILs to their expansion and functional testing, our integrated services are designed to meet the diverse needs of global clients. By integrating each stage of TIL development under one platform, we ensure continuity, consistency, and quality that expedite the journey from research to therapy.
Contact us today to explore how our experts support your journey in developing TIL therapies.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
